https://www.selleckchem.com/pr....oducts/msu-42011.htm
05). NSD patients had a significantly lower Disease Free Survival and Overall Survival (all p 0.0001), even after adjusting by demographic, clinic-pathological, tumor, and treatment characteristics. SD tumors were associated with better long-term outcomes, even after multiple adjustments. Our results confirm the advantages for the target population to participate in the screening programs and comply with their therapeutic pathways. SD tumors were associated with better long-term outcomes, even after multiple adjustments. Our resu